An inquiry into the ImClone cancer-drug story :  hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002. 

 - Washington :  U.S. G.P.O. :  For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office],  2002. 
 - iii, 759 pages :  illustrations ;  24 cm 
<br/><br/> "Serial no. 107-142."  Shipping list no.: 2003-0183-M.  CRDP Program record. 
<br/><br/>Includes bibliographical references. 
<br/><br/><br/>Microfiche. <br/>Washington : <br/>Supt. of Docs., U.S. G.P.O., <br/>2003. <br/>9 microfiches : negative. 
<br/><br/><label>Subjects--Corporate Names: </label><br/>ImClone Systems Incorporated--Corrupt practices.
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cetuximab--Testing.<br/>Drugs--Testing.--United States<br/>Insider trading in securities--United States.
<br/><br/><label>GPO Item No.: </label>1019-B-01 (MF) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.C 73/8:107-142 
<br/><br/><label>Report. No.: </label>Serial no. 107-142 (United States. Congress. House. Committee on Energy and Commerce)